Stay updated on Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Adds Lung cancer topic under MedlinePlus Genetics and updates to v3.0.2; removes the Back to Top element and the old v3.0.1 revision.
    Difference
    0.5%
    Check dated 2025-09-13T16:59:36.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T14:31:43.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility names and specific drug names, such as Albumin-Bound Paclitaxel and pembrolizumab, while removing several related terms and categories, indicating a shift in focus towards specific treatments and facilities.
    Difference
    3%
    Check dated 2025-08-30T11:19:54.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:28:37.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-08T23:49:16.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-01T19:17:27.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Nab-Paclitaxel in NSCLC Clinical Trial page.